A wearable, discreet cardiovascular vital signs monitor
developed at the University of Technology, Sydney (UTS) and a portable device
for diagnosing the severity of whiplash from The University of Queensland (UQ)
are among more than 25 cutting edge medical innovations that leading university
research commercialisation company UniQuest will be promoting at the 2011
Medica conference, Europes largest medical technology industry meeting.
Held in Dusseldorf,
Germany, from
16 – 19 November, this years event is expected to attract nearly 140,000
participants.
Other new technologies featured in UniQuests ‘medtech
portfolio include drug delivery and formulation mechanisms; monitoring,
diagnostics and screening systems; clinical practice management and training
tools; and Allied Health and assistive technologies to help patients recover
from stroke, injury and the side effects of disease treatments (full list
available on https://www.uniques t.com.au/medical-devices).
“Medica is the worlds largest medical innovation trade
fair, so its the ideal place for showcasing technologies emerging from
Australian university research that are addressing global health issues, such
as access, aging populations and preventable diseases,” said UniQuest Managing
Director, David Henderson.
“With about half the delegates from European Union countries
and the remainder from Asia, the Americas
and Africa, Medica presents a valuable
opportunity for UniQuest to talk to major international companies about the
competitive edge to be gained from licensing our technologies, and about
collaborating with Australian researchers to improve health outcomes around the
world.
“Medica also attracts investors looking to be involved with
the next blockbuster medical innovation, and the comparative strength of the
national economy has positioned Australia
within their sights. UniQuest-licensed innovati ons, for example, are now
generating annual sales of more than A$3 billion globally, from vaccines like
Gardasil to high-tech MRI machines and telehealth systems, so theres a lot of
interest in what the research institutions we represent are working on right
now to benefit future generations.”
UniQuests medical technology portfolio includes innovations
from its commercialisation partners: The University of Queensland, University
of Technology, Sydney, University of Wollongong, Mater Medical Research
Institute, James Cook University, University of Tasmania, and Queensland
Health.
UniQuests projects are among the 1000+ Australian
biotechnology and medical technology enterprises contributing to the industrys
global growth. Of the 151 healthcare and biotech companies listed on the
Australian Securities Exchange, 27 were capitalised at greater than A$100
million this year.
About UniQuest Pty Limited
Established by The University of Queensland in 1984, UniQuest is widely
recognised as one of Australias
largest and most successful university commercialisation groups, benchmarking
in the top tier of technology transfer worldwide. From an intellectual property
portfolio of 1,500+ patents it has created over 60 companies, and since 2000
UniQuest and its start-ups have raised more than $400 million to take
university technologies to market. Annual sales of products using UQ technology
and licensed by UniQuest are running at $3 billion. UniQuest now commercialises
innovations developed at The University of Queensland and its commercialisation
partner institutions: the University
of Wollongong, University
of Technology Sydney, James Cook University, University of Tasmania,
Mater Medical Research Institute, and Queensland Health. UniQuest also provides
access to an expansive and exclusive network of independent academics to tailor
a consulting or project R&D solution to me et the diverse needs of industry
and government, facilitating some 500 consulting, expert opinion, testing, and
contract research services each year. UniQuest is also a leading Australasian
provider of international development assistance recognised for excellence in
technical leadership, management and research. Working with agencies such as
AusAID, NZAID, the Asian Development Bank and the World Bank, UniQuest has
developed and implemented more than 400 projects in 46 countries throughout the
Pacific, South-East Asia, the Indian sub-continent and Africa.
www.uniquest.com.au
